Sumitomo Pharma Co., Ltd. (DNPUF)

Sumitomo Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 3, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	4,785	1,934	1,045	2,421	3,952	6,922
Market Cap Growth	193.62%	85.01%	-56.82%	-38.75%	-42.91%	33.63%
Enterprise Value	6,690	3,864	3,527	2,604	4,995	8,376
Last Close Price	12.07	4.76	2.40	6.38	10.22	18.75
PE Ratio	36.52	12.26	-	-	8.51	13.62
PS Ratio	1.66	0.73	0.50	0.58	0.86	1.48
PB Ratio	3.92	1.71	1.01	0.79	0.71	1.18
P/TBV Ratio	-	-	-	-	34.15	37.03
P/FCF Ratio	20.49	36.19	-	92.74	20.09	5.91
P/OCF Ratio	16.69	17.55	-	26.96	15.36	5.65
EV/Sales Ratio	2.44	1.45	1.70	0.62	1.08	1.80
EV/EBITDA Ratio	17.05	15.00	-	-	6.17	12.04
EV/EBIT Ratio	28.47	44.43	-	-	10.12	17.06
EV/FCF Ratio	28.65	72.31	-	99.75	25.39	7.15
Debt / Equity Ratio	1.76	1.85	2.74	0.85	0.42	0.45
Debt / EBITDA Ratio	5.07	8.14	-	-	2.89	3.78
Debt / FCF Ratio	9.18	39.27	-	99.82	11.91	2.24
Asset Turnover	0.52	0.48	0.31	0.46	0.43	0.40
Inventory Turnover	1.57	1.46	1.21	1.85	1.64	1.61
Quick Ratio	0.46	0.43	0.25	0.65	1.27	1.19
Current Ratio	1.11	1.07	0.52	1.03	1.79	1.65
Return on Equity (ROE)	11.21%	14.52%	-111.89%	-17.90%	6.14%	5.75%
Return on Assets (ROA)	2.90%	0.99%	-21.74%	-6.46%	2.86%	2.65%
Return on Capital (ROIC)	4.48%	1.52%	-33.20%	-9.23%	3.95%	3.60%
Return on Capital Employed (ROCE)	7.40%	2.60%	-	-	5.80%	5.30%
Earnings Yield	2.74%	8.16%	-199.19%	-23.15%	11.75%	7.34%
FCF Yield	4.88%	2.76%	-159.79%	1.08%	4.98%	16.92%
Dividend Yield	-	-	-	2.48%	2.26%	1.35%
Payout Ratio	0.02%	0.01%	-	-	19.72%	19.78%
Total Shareholder Return	-	-	-	2.48%	2.26%	1.35%

Updated Jan 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.